APA (7th ed.) Citation

Nilsson, M. B., Yang, Y., Heeke, S., Patel, S. A., Poteete, A., Udagawa, H., . . . Heymach, J. V. (2023). CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance. Cancer cell, 41(2), 340-355.e6. https://doi.org/10.1016/j.ccell.2023.01.007

Chicago Style (17th ed.) Citation

Nilsson, Monique B., et al. "CD70 Is a Therapeutic Target Upregulated in EMT-associated EGFR Tyrosine Kinase Inhibitor Resistance." Cancer Cell 41, no. 2 (2023): 340-355.e6. https://doi.org/10.1016/j.ccell.2023.01.007.

MLA (9th ed.) Citation

Nilsson, Monique B., et al. "CD70 Is a Therapeutic Target Upregulated in EMT-associated EGFR Tyrosine Kinase Inhibitor Resistance." Cancer Cell, vol. 41, no. 2, 2023, pp. 340-355.e6, https://doi.org/10.1016/j.ccell.2023.01.007.